Xingguang Cai

598 total citations
21 papers, 456 citations indexed

About

Xingguang Cai is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Microbiology. According to data from OpenAlex, Xingguang Cai has authored 21 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Microbiology. Recurrent topics in Xingguang Cai's work include Diabetes Treatment and Management (9 papers), Antimicrobial Peptides and Activities (8 papers) and Neuropeptides and Animal Physiology (5 papers). Xingguang Cai is often cited by papers focused on Diabetes Treatment and Management (9 papers), Antimicrobial Peptides and Activities (8 papers) and Neuropeptides and Animal Physiology (5 papers). Xingguang Cai collaborates with scholars based in China, Switzerland and Israel. Xingguang Cai's co-authors include Jean‐Louis Reymond, Thilo Köhler, Wenlong Huang, Hai Qian, Yuxuan Dai, Christian van Delden, Alice Capecchi, Wei Shi, Bee‐Ha Gan and Sacha Javor and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Carbohydrate Polymers.

In The Last Decade

Xingguang Cai

21 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingguang Cai China 14 296 152 116 69 60 21 456
Pegah Varamini Australia 15 440 1.5× 63 0.4× 19 0.2× 16 0.2× 141 2.4× 42 772
Qin Pan China 9 164 0.6× 65 0.4× 25 0.2× 14 0.2× 23 0.4× 18 354
Cécile Galanth France 9 360 1.2× 272 1.8× 32 0.3× 111 1.6× 35 0.6× 10 577
Shinichiro Tajiri Japan 6 192 0.6× 21 0.1× 18 0.2× 19 0.3× 15 0.3× 8 363
Sofie Stalmans Belgium 14 475 1.6× 136 0.9× 5 0.0× 14 0.2× 19 0.3× 22 664
Youn Bok Chung South Korea 13 165 0.6× 29 0.2× 8 0.1× 21 0.3× 33 0.6× 39 446
Cátia Moreira Portugal 10 334 1.1× 6 0.0× 25 0.2× 81 1.2× 24 0.4× 14 533
Zhijun Li United States 15 483 1.6× 11 0.1× 71 0.6× 16 0.2× 32 0.5× 38 620
A. Prasanth Saraswati Italy 10 295 1.0× 72 0.5× 5 0.0× 13 0.2× 163 2.7× 13 531
Dejing Shang China 11 179 0.6× 213 1.4× 8 0.1× 5 0.1× 34 0.6× 23 388

Countries citing papers authored by Xingguang Cai

Since Specialization
Citations

This map shows the geographic impact of Xingguang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingguang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingguang Cai more than expected).

Fields of papers citing papers by Xingguang Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingguang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingguang Cai. The network helps show where Xingguang Cai may publish in the future.

Co-authorship network of co-authors of Xingguang Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xingguang Cai. A scholar is included among the top collaborators of Xingguang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingguang Cai. Xingguang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gan, Bee‐Ha, Xingguang Cai, Robert Rauscher, et al.. (2024). Stereorandomized Oncocins with Preserved Ribosome Binding and Antibacterial Activity. Journal of Medicinal Chemistry. 67(21). 19448–19459. 2 indexed citations
2.
Cai, Xingguang, et al.. (2023). Exploring the Sequence Space of Antimicrobial Peptide Dendrimers. Israel Journal of Chemistry. 63(10-11). 3 indexed citations
3.
Cai, Xingguang, Alice Capecchi, Thilo Köhler, et al.. (2022). An intrinsically disordered antimicrobial peptide dendrimer from stereorandomized virtual screening. Cell Reports Physical Science. 3(12). 101161–101161. 10 indexed citations
4.
Cai, Xingguang, Sacha Javor, Bee‐Ha Gan, Thilo Köhler, & Jean‐Louis Reymond. (2021). The antibacterial activity of peptide dendrimers and polymyxin B increases sharply above pH 7.4. Chemical Communications. 57(46). 5654–5657. 20 indexed citations
5.
Patrulea, Viorica, Bee‐Ha Gan, Karl Perron, et al.. (2021). Synergistic effects of antimicrobial peptide dendrimer-chitosan polymer conjugates against Pseudomonas aeruginosa. Carbohydrate Polymers. 280. 119025–119025. 41 indexed citations
6.
Capecchi, Alice, et al.. (2021). Machine learning designs non-hemolytic antimicrobial peptides. Chemical Science. 12(26). 9221–9232. 114 indexed citations
7.
Liu, Chunxia, Chengye Li, Xingguang Cai, et al.. (2020). Discovery of a novel GLP-1/GIP dual receptor agonist CY-5 as long-acting hypoglycemic, anti-obesity agent. Bioorganic Chemistry. 106. 104492–104492. 14 indexed citations
8.
Li, Chengye, Xingguang Cai, Yuxuan Dai, et al.. (2019). Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties. Bioorganic & Medicinal Chemistry. 27(20). 115070–115070. 2 indexed citations
9.
Dai, Yuxuan, Xingguang Cai, Chunxia Liu, et al.. (2019). Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance. European Journal of Medicinal Chemistry. 171. 104–115. 20 indexed citations
10.
Dai, Yuxuan, Chunxia Liu, Xingguang Cai, et al.. (2019). Synthesis and evaluation of redox-sensitive gonadotropin-releasing hormone receptor-targeting peptide conjugates. Bioorganic Chemistry. 88. 102945–102945. 4 indexed citations
11.
Cai, Xingguang, Chengye Li, Jie Zhou, et al.. (2019). Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties. Bioorganic Chemistry. 95. 103538–103538. 9 indexed citations
12.
Cai, Xingguang, Lidan Sun, Yuxuan Dai, et al.. (2018). Novel fatty acid chain modified GLP-1 derivatives with prolonged in vivo glucose-lowering ability and balanced glucoregulatory activity. Bioorganic & Medicinal Chemistry. 26(9). 2599–2609. 10 indexed citations
13.
Dai, Yuxuan, Xingguang Cai, Wei Shi, et al.. (2017). Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane. Amino Acids. 49(9). 1601–1610. 42 indexed citations
14.
Li, Zheng, Chunxia Liu, Wei Shi, et al.. (2017). Identification of highly potent and orally available free fatty acid receptor 1 agonists bearing isoxazole scaffold. Bioorganic & Medicinal Chemistry. 26(3). 703–711. 15 indexed citations
15.
Zhou, Jie, Xingguang Cai, Xun Huang, et al.. (2017). A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects. European Journal of Medicinal Chemistry. 138. 1158–1169. 33 indexed citations
16.
Li, Zheng, Chunxia Liu, Xue Xu, et al.. (2017). Design, synthesis, and biological evaluation of deuterated phenylpropionic acid derivatives as potent and long-acting free fatty acid receptor 1 agonists. Bioorganic Chemistry. 76. 303–313. 14 indexed citations
17.
Yang, Jianyong, Zheng Li, Huilan Li, et al.. (2017). Design, synthesis and structure–activity relationship studies of novel free fatty acid receptor 1 agonists bearing amide linker. Bioorganic & Medicinal Chemistry. 25(8). 2445–2450. 20 indexed citations
18.
Sun, Lidan, Xun Huang, Jing Han, et al.. (2016). Site-specific fatty chain-modified exenatide analogs with balanced glucoregulatory activity and prolonged in vivo activity. Biochemical Pharmacology. 110-111. 80–91. 20 indexed citations
19.
Li, Zheng, Miaobo Pan, Xin Su, et al.. (2016). Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry. 24(9). 1981–1987. 30 indexed citations
20.
Sun, Lidan, Chuandong Wang, Yuxuan Dai, et al.. (2015). Coumaglutide, a novel long-acting GLP-1 analog, inhibits β-cell apoptosis in vitro and invokes sustained glycemic control in vivo. European Journal of Pharmacology. 767. 211–219. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pegah Varamini Breakdown of academic impact, for papers by Qin Pan Breakdown of academic impact, for papers by Cécile Galanth Breakdown of academic impact, for papers by Shinichiro Tajiri Breakdown of academic impact, for papers by Sofie Stalmans Breakdown of academic impact, for papers by Youn Bok Chung Breakdown of academic impact, for papers by Cátia Moreira Breakdown of academic impact, for papers by Zhijun Li Breakdown of academic impact, for papers by A. Prasanth Saraswati Breakdown of academic impact, for papers by Dejing Shang
Rankless by CCL
2026